The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
BCG lmmunotherapy of Malignant Melanoma: Summary of a Seven-year Experience
Open accessAbstract
Over the past 7 years, 151 patients with malignant melanoma have been treated with BCG immunotherapy alone or as an adjunct to surgical therapy. Direct injection of metastatic melanoma lesions limited to skin resulted in 90% regression of injected lesions and 17% regression of uninjected lesions in immunocompetent patients. Approximately 25% of these patients remained free of disease for 1 to 6 years. Direct injections of BCG into nodules of patients with subcutaneous or visceral metastases resulted in a lower incidence of local control and no long term survivors. Attempts to improve the results of immunotherapy in these patients by palliative surgical resection of large metastatic lesions to lower tumor burden followed by BCG immunotherapy significantly improved the results although many patients still developed recurrent disease. Early results of a clinical trial combining BCG immunotherapy with regional lymphadenectomy in patients with melanoma metastatic to lymph nodes have been encouraging and promising. Further controlled clinical trials are necessary to elucidate the role of BCG in immunotherapy. However, since BCG is but one of a number of potential immunologic adjuvants, even more effective immunotherapy will be possible as further knowledge of the interactions of cellular and humoral immunity is acquired.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maximum utilization of the life table method in analyzing survival
Cutler, S. J., & Ederer, F. (1958) · Journal of Chronic Diseases · doi:10.1016/0021-9681(58)90126-7 · Cited by 2,870
Impaired immunologic reactivity and recurrence following cancer surgery
Eilber, F. R., & Morton, D. L. (1970) · Cancer · doi:10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v · Cited by 665
Self-citationImmunological factors which influence response to immunotherapy in malignant melanoma.
Morton, D. L., Eilber, F. R., Malmgren, R. A., & Wood, W. C. (1970) · PubMed · Cited by 461
Self-citationLewis, M. G., Ikonopisov, R. L., Nairn, R. C., Phillips, T. M., Fairley, G. H., Bodenham, D. C., & Alexander, P. (1969) · BMJ · doi:10.1136/bmj.3.5670.547 · Cited by 392
Demonstration of antibodies against human malignant melanoma by immunofluorescence.
Dl, M., Malmgren, R. A., Ec, H., & Ketcham, A. S. (1968) · PubMed · Cited by 386
Self-citationComplications of BCG Immunotherapy in Patients with Cancer
Sparks, F. C., Silverstein, M. J., Hunt, J. S., et al. (1973) · New England Journal of Medicine · doi:10.1056/nejm197310182891603 · Cited by 214
Self-citationNon-specific and specific immunotherapy in patients with melanoma.
Seigler, H. F., Shingleton, W. W., Metzgar, R. S., et al. (1972) · PubMed · Cited by 96
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Nabel, G. J., Nabel, E. G., Yang, Z. Y., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., & Chang, A. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11307 · Cited by 882
The mechanism of action of BCG therapy for bladder cancer--a current perspective
Redelman-Sidi, G., Glickman, M. S., & Bochner, B. H. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.15 · Cited by 729
Therapeutic targeting of trained immunity
Mulder, W. J. M., Ochando, J., Joosten, L. A. B., Fayad, Z. A., & Netea, M. G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0025-4 · Cited by 443
MORTON, D. L., FOSHAG, L. J., HOON, D. S. B., NIZZE, J. A., WANEK, L. A., CHANG, C., DAVTYAN, D. G., GUPTA, R. K., ELASHOFF, R., & IRIE, R. F. (1992) · Annals of Surgery · doi:10.1097/00000658-199210000-00010 · Cited by 403
Self-citation
Metadata
- Authors
- MORTON, D. L., EILBER, F. R., HOLMES, E. C., HUNT, J. S., KETCHAM, A. S., SILVERSTEIN, M. J., & SPARKS, F. C.
- Venue
- Annals of Surgery
- Published
- 1974-10
- Volume
- 180
- Issue
- 4
- Pages
- 635-643
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2057577614
- Cited by
- 449
- References
- 7
- FWCI
- 17.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BCG lmmunotherapy of Malignant Melanoma: Summary of a Seven-year Experience. https://app.cochat.ai/papers/10.1097/00000658-197410000-00029
- The paper
- MORTON, D. L., EILBER, F. R., HOLMES, E. C., HUNT, J. S., KETCHAM, A. S., SILVERSTEIN, M. J., & SPARKS, F. C. (1974). BCG lmmunotherapy of Malignant Melanoma: Summary of a Seven-year Experience. Annals of Surgery. https://doi.org/10.1097/00000658-197410000-00029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.